Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line

Autonomic and Autacoid Pharmacology

Volumn 29, Issue 3, 2009, Pages 109-115

  Cabadak, H ^a   Kucukibrahimoglu E ^a   Aydin, B ^a   Kan, B ^a   Gören, M Zafer ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

4 DAMP; Arginine; Carbachol; Citrulline; NO; Tropicamide

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ARGININE; ATROPINE; CARBACHOL; CITRULLINE; MUSCARINIC AGENT; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECEPTOR SUBTYPE; RNA; TROPICAMIDE;

ARTICLE; CELL STRAIN K 562; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; MICRODIALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ARGININE; CARBACHOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CITRULLINE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; K562 CELLS; MICRODIALYSIS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PIPERIDINES; RECEPTORS, MUSCARINIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TROPICAMIDE;

EID: 67651046521     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2009.00431.x     Document Type: Article

References (44)

1. BACMAN, S., BERRA, A., STERIN-BORDA, L. BORDA, E. (2001). Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sjögren syndrome. Invest. Ophthalmol. Vis. Sci., 42, 321 327. (Pubitemid 32121458)
2. BEAUREGARD, C., BRANDT, P.C. CHIOU, G.C. (2002). Nitric oxide and cyclic GMP-mediated protein secretion from cultured lacrimal gland acinar cells. J. Ocul. Pharmacol. Ther., 18, 429 443. (Pubitemid 37420252)
3. BRANN, M.R., BUCKLEY, N. BONNER, T.I. (1988). The striatum and cerebral cortex express different muscarinic receptor mRNAs. FEBS Lett., 230, 90 94. (Pubitemid 18089751)
4. CAULFIELD, M.P. (1993). Muscarinic receptors: characterization, coupling and function. Pharmacol. Ther., 58, 319 379. (Pubitemid 23273186)
5. CHOMCYNSKI, P. SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162, 156 159. (Pubitemid 17064313)
6. CUADRA, A.E. EL-FAKAHANY, E.E. (2005). Mechanism of M1 muscarinic receptor-mediated up-regulation of neuronal nitric oxide synthase in N1E-115 neuroblastoma cells. Brain Res. Mol. Brain Res., 134, 198 204.
7. DECKER, N.K., ABDELMONEIM, S.S., YAQOOB, U., HENDRICKSON, H., HORMES, J., BENTLEY, M., PITOT, H., URRUTIA, R., GORES, G.J. SHAH, V.H. (2008). Nitric oxide regulates tumor cell cross-talk with stromal cells in the tumor microenvironment of the liver. Am. J. Pathol., 173, 1002 1012.
8. DIMAGNO, M.J., HAO, Y., TSUNODA, Y., WILLIAMS, J.A. OWYANG, C. (2004). Secretagogue-stimulated pancreatic secretion is differentially regulated by constitutive NOS isoforms in mice. Am. J. Physiol. Gastrointest. Liver Physiol., 286, G428 G436.
9. 5 receptor: a silent or emerging subtype? Br. J. Pharmacol., 130, 13 21. (Pubitemid 30248420)
10. EGLEN, R.M. WATSON, N. (1996). Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol., 78, 59 68. (Pubitemid 26042759)
11. EGLEN, R.M. WHITING, R.L. (1990). Heterogeneity of vascular muscarinic receptors. J. Auton. Pharmacol., 19, 187 200.
12. EGLEN, R.M., REDD, H. WATSON, N. (1994). Muscarinic receptor subtypes in smooth muscle. Trends Pharmacol. Sci., 5, 114 119.
13. ENGELS, K., KNAUER, S.K., LOIBL, S. et al. (2008). NO signaling confers cytoprotectivity through the survivin network in ovarian carcinomas. Cancer Res., 68, 5159 5166.
14. ESPANOL, A.J. SALES, M.A. (2004). Different muscarinic receptors are involved in the proliferation of murine mammary adenocarcinoma cell lines. Int. J. Mol. Med., 13, 311 317.
15. FELDER, C.C. (1995). Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J., 9, 619 625.
16. FURFINE, E.S., HARMON, M.F., PAITH, J.E., KNOWLES, R.G., SALTER, M., KIFF, R.J., DUFFY, C., HAZELWOOD, R., OPLINGER, J.A. GARVEY, E.P. (1994). Potent and selective inhibition of human nitric oxide synthases. Selective inhibition of neuronal nitric oxide synthase by S-methyl-L-thiocitrulline and S-ethyl-L-thiocitrulline. J. Biol. Chem., 269, 26677 26683.
17. GOYAL, R.K. (1989). Muscarinic receptor subtypes: physiology and clinical implications. N. Engl. J. Med., 321, 1022 1029. (Pubitemid 19253417)
18. + channels and muscarinic and purinergic receptors identified in human erythroid progenitor cells and red blood cell ghosts. Proc. Natl Acad. Sci. USA, 101, 12370 12374. (Pubitemid 39145450)
19. HULME, E.C., BIRDSDALL, N.J.M. BUCKLEY, N.Y. (1990). Muscarinic receptor subtypes. Annu. Rev. Pharmacol. Toxicol., 30, 633 673. (Pubitemid 20139559)
20. HUSSAIN, S.P., HE, P., SUBLESKI, J. et al. (2008). Nitric oxide is a key component in inflammation-accelerated tumorigenesis. Cancer Res., 68, 7130 7136.
21. KAMIMURA, Y., FUJII, T., KOJIMA, H., NAGANO, T. KAWASHIMA, K. (2003). Nitric oxide (NO) synthase mRNA expression and NO production via muscarinic acethylcholine receptor-mediated pathways in the CEM, human leukaemic T-cell line. Life Sci., 72, 2151 2154. (Pubitemid 36298961)
22. 2+in Jurkat, a human leukemic helper T lymphocyte line. Mol. Pharmacol., 43, 356 364. (Pubitemid 23081991)
23. KAWASHIMA, K. FUJII, T. (2004). Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front. Biosci., 9, 2063 2085.
24. KNOWLES, R.G. MONCADA, S. (1994). Nitric oxide synthases in mammals. Biochem. J., 298, 249 258. (Pubitemid 24072462)
25. LOZZIO, C.B. LOZZIO, B.B. (1975). Human chronic myelogenous leukemia cellline with positive Philadelphia chromosome. Blood, 45, 321 334.
26. MAGRINAT, G., MASON, S.N., SHAMI, P.J. WEINBERG, J.B. (1992). Nitric oxide modulation of human leukemia cell differentiation and gene expression. Blood, 80, 1880 1884.
27. MCINTYRE, R. QUINN, P. (1995). Characterisation and comparison of muscarinic receptors in the dog ciliary muscle with ileum. Br. J. Pharmacol., 115, 139P.
28. MCVARY, K.T., MCKENNA, K.E. LEE, C. (1999). Prostate innervation. Prostate, 8 (Suppl 2 13. (Pubitemid 28347989)
29. MONCADA, S., PALMER, R. M. HIGGS, E. A. (1991). Nitric oxide physiology, pathophysiology and pharmacology. Pharmacol. Rev., 43, 109 142.
30. NATHAN, C. (1992). Nitric oxide as a secretory product of mammalian cells. FASEB J., 6, 3051 3064.
31. NATHAN, C.F. XIE, Q.W. (1994a). Nitric oxide synthases: roles, tolls and controls. Cell, 78, 915 918.
32. NATHAN, C. XIE, Q.W. (1994b). Regulation of biosynthesis of nitric oxide. J. Biol. Chem., 269, 13725 13728. (Pubitemid 24191108)
33. PHILLIPS, J.K., VIDOVIC, M. HILL, C.E. (1997). Variation in mRNA expression of α-adrenergic, neurokinin and muscarinic receptors amongst four arteries of the rat. J. Auton. Nerv. Syst., 62, 85.
34. RAYFORD, W., NOBLE, M.J., AUSTENFELD, M.A., WEIGEL, J., MEBUST, W.K. SHAH, G.V. (1997). Muscarinic cholinergic receptors promote growth of human prostate cancer cells. Prostate, 30, 160 166. (Pubitemid 27149274)
35. RODENBURG, R.J.T., VAN DEN HOOGEN, F.H.J., VAN DE PUTTE, L.B.A VAN VENROOIJ, W.J. (1998). Peripheral blood monocytes of rheumotoid arthritis patients do not express elevated TNF α, IL-1 β and IL-8 mRNA levels. A comparison of monocyte isolation procedures. J. Immunol. Methods, 221, 169 175. (Pubitemid 29017933)
36. ROSIGNOLI, F. LEIROS, C.P. (2002). Activation of nitric oxide synthase through muscarinic receptors in rat parotid gland. Eur. J. Pharmacol., 439, 27 33. (Pubitemid 34286603)
37. SATO, K.Z., FUJII, T., WATANABE, Y., YAMADA, S., ANDO, T., FUJIMOTO, K. KAWASHIMA, K. (1999). Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemia cell lines. Neurosci. Lett., 266, 17 20. (Pubitemid 29219745)
38. SERRA, P.A., ROCCHITTA, G., DELOGU, M.R., MIGHELI, R., TARAS, M.G., MURA, P., ESPOSITO, G., MIELE, E., DESOLE, M.S. MIELE, M. (2003). Role of nitric oxide/cyclic GMP pathway and and extracellular environment in the nitric oxide donor-induced increase in dopamine secretion from PC12 cells: a microdialysis in vitro study. J. Neurochem., 86, 1403 1413. (Pubitemid 37174257)
39. STEEL, M.C. BUCKLEY, N.J. (1993). Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure: A comparative polymease chain reaction study. Mol. Pharmacol., 43, 694 701. (Pubitemid 23146266)
40. TAYEBATI, S.K., CODINI, M., GALLUI, V., MANNINO, F., PARNETTI, I., RICCI, A., SARCHIELLI, P. AMENTA, F. (1999). Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol., 99, 224 229. (Pubitemid 29518235)
41. TRACEY, W.R. PEACH, M.J. (1992). Differential muscarinic receptor mRNA expression by freshly isolated and cultured bovine aortic endothelial cells. Circulation Res., 70, 234 240.
42. WANG, S.Z., ZHU, S.Z. EL-FAKAHANY, E. (1994). Efficient coupling of M5 muscarinic acetylcholine receptors to activation of nitric oxide synthase. J. Pharmacol. Exp. Ther., 268, 552 557. (Pubitemid 24085845)
43. WANG, J., KRYSIAK, P.S., LAURIRER, L.G., SIMS, S.M. PREIKSAITIS, H.G. (2000). Human esophageal smooth muscle cells express muscarinic receptor subtypes m1 through m5. Am. J. Physiol. Gastrointest. Liver Physiol., 279, G1059 G.
44. WESSLER, I. KIRKPATRICK, C.J. (2008). Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol., 154, 1558 1571.